The manufacturer of the weight-loss drug Mounjaro has paused shipments to the UK before a significant price rise for the treatment next month.
The US pharmaceutical company Eli Lilly is due to increase the UK list price of the drug by up to 170% from September amid a White House push to get drugmakers to raise medicine prices in Europe to allow for price cuts in the US.